AmberGen and Massachusetts General Hospital license the use of two novel autoantigen biomarkers for autoimmune liver disease to INOVA Diagnostics http://www.marketwired.com/press-release/ambergen-mass-general-license-two-novel-autoantigen-biomarkers-autoimmune-liver-disease-1631270.htm
